Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
Sign Up to like & getrecommendations! Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00714-8
Abstract: Background The association between treatment-related lymphopenia in multiple sclerosis, drug efficacy and the risk of infections is not yet fully understood. Objective The objective of this study was to assess whether lymphopenia is associated with… read more here.
Keywords: treatment response; treatment; odds ratio; fingolimod dimethyl ... See more keywords